Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Have $1,500? 2 Top Growth Stocks to Buy Right Now for 2024 and Beyond
March 31, 2024
Great companies in steadily growing industries can deliver enviable returns through the years.
Via
The Motley Fool
3 Unstoppable Stocks to Buy Hand Over Fist in April
March 30, 2024
These stocks have exceptionally bright prospects.
Via
The Motley Fool
Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
March 29, 2024
Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair...
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
The 3 Best Biotech Stocks to Buy in Q2 2024
March 29, 2024
Biotech can be a risky industry for investors, but we've done the legwork for you with these three biotech stocks for Q2.
Via
InvestorPlace
Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
March 29, 2024
The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried about the sustainability of the uptrend.
Via
Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
March 27, 2024
Via
Benzinga
The Best Stocks to Invest $10,000 in Right Now
March 25, 2024
These elite enterprises can help you grow richer.
Via
The Motley Fool
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
March 28, 2024
The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years
March 28, 2024
Via
Benzinga
Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
March 28, 2024
Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.
Via
The Motley Fool
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
March 28, 2024
Invest in stability, dividends, and growth with these three accomplished real estate operators.
Via
The Motley Fool
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
March 28, 2024
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.
Via
The Motley Fool
7 Stocks That Will Drive the Weight Loss Drugs Market
March 28, 2024
The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis.
Via
MarketBeat
Prediction: This Will Be the Next "Magnificent Seven" Stock
March 28, 2024
This particular company's growth is set to take off...
Via
The Motley Fool
US Companies In Japan Wary On Market Intervention As Yen Hits 34-Year Low Vs. Dollar
March 27, 2024
The Japanese yen fell Wednesday to a 34-year low against the dollar, which is a boon for exporters, but imports are more expensive.
Via
Benzinga
The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months
March 27, 2024
Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months.
Via
InvestorPlace
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
March 26, 2024
Krispy Kreme's partnership with McDonald's has led to a surge in stock prices. Investors are turning to insulin stocks to capitalize on the growing demand.
Via
Benzinga
Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
March 26, 2024
Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its...
Via
Benzinga
Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
March 26, 2024
People lost more weight than the company expected over a 28-day study.
Via
Investor's Business Daily
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.
Via
Talk Markets
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
March 26, 2024
All three of these high-flying stocks could have more room to run.
Via
The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
March 26, 2024
Find out why investment banks up and down Wall Street have big expectations for these stocks.
Via
The Motley Fool
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
March 26, 2024
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via
Investor's Business Daily
Biotechnology And Healthcare, A Bit Of A Lull
March 25, 2024
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.
Via
Talk Markets
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Via
InvestorPlace
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
March 25, 2024
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.
Via
Benzinga
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
March 25, 2024
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
Via
The Motley Fool
Amazon’s AI Awakening: Why AMZN Stock Is the Magnificent Seven’s Sleeping Giant
March 25, 2024
While garnering relatively less attention than its "Magnificent Seven" peers, AMZN stock is a top buy among this elite set of tech stocks.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Hedge Funds Are Fleeing Tech: 7 Stocks They’re Buying Instead
March 24, 2024
Although tech remains a hot commodity, these stocks hedge funds are buying suggest that a high-level rotation is occurring.
Via
InvestorPlace
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.